LAUREN GREEN: Open Payments
NPI 1144812371 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 36 payments from 11 companies in 2025. Trend: 2023 $859 · 2024 $694 · 2025 $751
Food & beverage: $747Education: $3
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $168 |
| AKEBIA THERAPEUTICS INC | 5 | $142 |
| OPKO Pharmaceuticals, LLC | 5 | $87 |
| Novo Nordisk Inc | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Mallinckrodt Hospital Products Inc. | 2 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Aurinia Pharma U.S., Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| Travere Therapeutics, Inc. | 3 | $27 |
Products named: Fabhalta, Vafseo, RAYALDEE, ACTHAR, Vanrafia, JYNARQUE, Kerendia, LUPKYNIS.
Industry payments across GA — which companies pay providers there.
